Exchange: NASDAQ·Updated 04:00 PM EDT
NGNE logo

NGNE Neurogene Inc

$33.69
$1.52
(4.32%)
Today
EarningsNov 12
Mkt Cap$704.6M
Vol147,611.00

About NGNE

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
53

Neutral Sentiment

How do you feel about NGNE?

Advertisement|Remove ads.